The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod in NCP. NCP is a chronic ocular pain syndrome with no FDA-approved therapies ...

Chronic pain affects over 50 million adults in the U.S. alone and is a leading cause of disability worldwide (Dahlhamer et al., 2018). Yet not all chronic pain is the same, and understanding what kind ...

Analyzing molecular changes in two types of peripheral nerves that are affected in diabetic peripheral neuropathy – the sural, which carry sensory signals, and the tibial, which carry both sensory and ...

Neuropathic pain is nerve pain coming from malfunctions of or damage to the nervous system (brain, spinal cord, peripheral nerves). It is different from pain messages that are carried along healthy ...

Please provide your email address to receive an email when new articles are posted on . Patients with hidradenitis suppurativa experienced sensory loss to innocuous cold and warmth, noxious heat and ...

While pain is a natural part of the healing process after an illness, injury, or surgery, it can become a condition in its own right. This can happen when the pain becomes more intense or lasts longer ...

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated review in the Cochrane Database of Systematic Reviews finds.

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated Cochrane review finds.